Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,066 | -102,985 | -82,495 | -52,531 | -24,068 |
| Depreciation Amortization | 1,911 | 10,947 | 9,274 | 4,024 | 2,032 |
| Accounts receivable | -160 | -10,438 | -2,161 | 2,290 | -2,271 |
| Other Working Capital | 4,190 | -4,781 | -5,060 | -1,851 | -4,359 |
| Other Operating Activity | -1,563 | 23,575 | 17,246 | 8,764 | 6,774 |
| Operating Cash Flow | $-21,688 | $-83,682 | $-63,196 | $-39,304 | $-21,892 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -458 | -5,964 | -4,597 | -2,839 | -526 |
| Purchase Sale Intangibles | N/A | -1,200 | -1,000 | N/A | -1,250 |
| Other Investing Activity | 0 | -1,200 | -1,000 | 0 | -1,250 |
| Investing Cash Flow | $-458 | $-7,164 | $-5,597 | $-2,839 | $-1,776 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 60,000 | 60,000 | N/A | N/A |
| Debt Repayment | -13 | -78,223 | -93,910 | N/A | N/A |
| Common Stock Issued | 165 | 46,479 | 58,181 | 37,502 | 182 |
| Common Stock Repurchased | N/A | -70 | -70 | -70 | -70 |
| Dividend Paid | -2,194 | -6,752 | -4,557 | -2,788 | -1,207 |
| Other Financing Activity | 80,734 | 150,976 | 115,751 | 53,919 | 23,848 |
| Financing Cash Flow | $78,692 | $172,410 | $135,395 | $88,563 | $22,753 |
| Beginning Cash Position | 234,996 | 153,432 | 153,432 | 153,432 | 153,432 |
| End Cash Position | 291,542 | 234,996 | 220,034 | 199,852 | 152,517 |
| Net Cash Flow | $56,546 | $81,564 | $66,602 | $46,420 | $-915 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,688 | -83,682 | -63,196 | -39,304 | -21,892 |
| Capital Expenditure | -458 | -5,964 | -4,597 | -2,839 | -526 |
| Free Cash Flow | -22,146 | -89,646 | -67,793 | -42,143 | -22,418 |